Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Publication stageIn Press Journal Pre-Proof
This article was funded by Eidos Therapeutics Inc., San Francisco, California. The International Congress on ATTR Amyloidosis was supported by Eidos and developed and produced in coordination with MedscapeLIVE! (New York, New York).
This article is based on a presentation given at the first Annual International Congress on ATTR Amyloidosis Conference on October 16, 2021.